Globus Medical
GMED
322 hedge funds and large institutions have $3.18B invested in Globus Medical in 2020 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 94 increasing their positions, 119 reducing their positions, and 30 closing their positions.
167% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 30
18% more funds holding
Funds holding: 273 → 322 (+49)
17% more call options, than puts
Call options by funds: $17.4M | Put options by funds: $15M
3% more capital invested
Capital invested by funds: $3.07B → $3.18B (+$107M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4.21% less ownership
Funds ownership: 93.3% → 89.09% (-4.2%)
21% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 119
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$31.3M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$30.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$28.2M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$20.1M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$13.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$90.3M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$49.1M |
| 3 |
Renaissance Technologies
New York
|
-$30.6M |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$30.6M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$29.8M |
GMED Hedge Fund Activity: Q2 2020 in Review
322 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2020, worth a combined $3.18B — up 3.5% from $3.07B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new GMED positions and 30 closed out — a net gain of 50 holders — while 94 added to existing stakes and 119 trimmed.
The largest buyer was Jane Street, adding an estimated $31.3M. The largest seller was BlackRock, cutting an estimated $90.3M.
- 322 institutional investors held Globus Medical (GMED) as of Q2 2020, up from 273 in Q1 2020.
- Funds reported $3.18B of Globus Medical stock for Q2 2020, up 3.5% quarter-over-quarter.
- 80 funds opened new Globus Medical positions in Q2 2020 and 30 closed out, a net change of +50 holders.
- The largest Globus Medical buyer in Q2 2020 was Jane Street, an estimated $31.3M added.
- The largest Globus Medical seller in Q2 2020 was BlackRock, an estimated $90.3M sold.
Based on aggregated 13F filings for Q2 2020.